Judge Concludes Lengthy Court Battle
A bankruptcy judge approved a $7.4bn settlement on Friday that obliges Purdue Pharma and its billionaire owners to pay for their role in the US opioid crisis. The ruling ends a prolonged legal battle aimed at holding the OxyContin-maker and the Sackler family accountable. It also releases long-delayed funds for people struggling with addiction. Purdue sought bankruptcy protection in 2019 after thousands of lawsuits accused the company of fuelling the opioid epidemic.
New Deal Tops Earlier Settlement Proposal
The agreement adds more than $1bn to an earlier deal rejected by the Supreme Court last year. Steve Miller, chairman of the Purdue board, said the settlement closes a long chapter and brings the case close to its final stage. He said the restructuring plan unlocks billions in recoveries and introduces key non-financial measures.
Nonprofit Successor Will Take Over Purdue
The Sacklers must surrender ownership of the company. A nonprofit named Knoa Pharma will assume control and dedicate itself to addressing the opioid crisis. Purdue became widely known for producing and promoting OxyContin, a painkiller linked to a path toward heroin and other dangerous drugs. The medication is blamed for accelerating a crisis tied to about 900,000 US deaths since 1999.
Lawsuits Target Aggressive OxyContin Marketing
Thousands of lawsuits accused Purdue and Sackler family members of aggressively marketing OxyContin while misleading doctors and patients about addiction and overdose risks. Purdue pleaded guilty in 2020 in a separate criminal case brought by the Department of Justice. That plea did not resolve the many civil lawsuits filed by states, local governments, tribal nations, and other groups, which helped drive the company into bankruptcy.
Supreme Court Rejects Sackler Immunity Plan
A previous settlement sought to shield the Sacklers from future civil lawsuits even though they did not declare bankruptcy. The Supreme Court ruled such protections unlawful. The new $7.4bn settlement grants the family no immunity from future opioid-related claims. The Sacklers are expected to contribute between $6.5bn and $7bn and continue to deny wrongdoing.
Victims Will Receive Compensation Funds
Some individuals argued earlier that the settlement still provided insufficient compensation. Individual victims may receive up to $865m. Despite concerns, the settlement received overwhelming support from government groups and personal injury claimants. Purdue said in October that more than 99% of creditors approved the restructuring plan.
States Plan to Expand Treatment Services
State and local governments will receive most of the settlement funds. Officials said the money will support addiction treatment, prevention programmes, and recovery services nationwide. California Attorney General Rob Bonta said in June that holding Purdue and the Sacklers responsible provides essential support to communities harmed by the crisis.
